CLPT - Clearpoint Neuro Inc logo

CLPT

Clearpoint Neuro Inc

Revenue grew 100% of years5Y
Hold

ClearPoint Neuro develops medical devices for minimally invasive brain surgeries, offering systems for navigation, drug delivery, and laser therapy. It also provides consulting services for clinical trials and research to support neurological treatments.

⚕️ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 10 years ago $1,786today

Score Overview

1 Year
Score
Net Growth-35.34%
Net TrendShrank
Net Income Consistency
Rev Growth14.36%
Rev TrendGrew
Revenue Consistency
5 Years
Score3.9
Net Growth-139.88%
Net Trend20%
Net Income Consistency
Rev Growth159.40%
Rev TrendEvery year
Revenue Consistency
All Time
Score
Net Growth-409.67%
Net Trend17%
Net Income Consistency
Rev Growth229.56%
Rev TrendEvery year
Revenue Consistency

See the full market ranking →

Clearpoint Neuro Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 12M to $ 36M and net income went from -$ 6M to -$ 25M. Revenue increased in every one of those 5 years; net income in 1.

Clearpoint Neuro Inc currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 15.18
1 Year2025-08-12
$ 10.5444.02%
5 Years2021-08-12
$ 18.53-18.08%
10 Years2016-08-12
$ 8.5078.59%
All Time2020-02-12
$ 5.61170.59%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 42M-$ 34M$ 29M
2025$ 36M-$ 25M$ 45M
2024$ 31M-$ 18M$ 20M
2023$ 23M-$ 22M$ 23M
2022$ 20M-$ 16M$ 37M
2021$ 16M-$ 14M$ 54M
IPO2020$ 12M-$ 6M$ 20M

Explore beyond CLPT

You're looking at Clearpoint Neuro Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies